Sep 24, 2024
George Church lab spawns $75m cell therapy startup
Posted by Cecile G. Tamura in categories: biotech/medical, genetics
GC Therapeutics’ plug-and-play stem cell programming platform aims to reduce cell therapy development time by up to 100 times.
Cell therapies have revolutionized the treatment of certain disease areas; however, challenges in scaling these therapies…
Cell therapy startup GC Therapeutics (GCTx) has emerged from the lab of renowned geneticist George Church, securing a $65 million Series A funding round that brings the total raised by the company to a cool $75 million. The company is on a mission to enable the next generation of cell therapies through its proprietary TFome platform, which GCTx claims is the first plug-and-play induced pluripotent stem cell (iPSC) cellular programming platform.
Continue reading “George Church lab spawns $75m cell therapy startup” »